EP2294064A4 - Process for purification of rabeprazole sodium - Google Patents

Process for purification of rabeprazole sodium

Info

Publication number
EP2294064A4
EP2294064A4 EP08808137A EP08808137A EP2294064A4 EP 2294064 A4 EP2294064 A4 EP 2294064A4 EP 08808137 A EP08808137 A EP 08808137A EP 08808137 A EP08808137 A EP 08808137A EP 2294064 A4 EP2294064 A4 EP 2294064A4
Authority
EP
European Patent Office
Prior art keywords
purification
rabeprazole sodium
rabeprazole
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08808137A
Other languages
German (de)
French (fr)
Other versions
EP2294064A2 (en
Inventor
Reddy Bandi Parthasaradhi
Reddy Kura Rathnakar
Reddy Rapolu Raji
Reddy Dasari Muralidhara
Reddy Jonnala Sambi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hetero Research Foundation
Original Assignee
Hetero Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Research Foundation filed Critical Hetero Research Foundation
Publication of EP2294064A2 publication Critical patent/EP2294064A2/en
Publication of EP2294064A4 publication Critical patent/EP2294064A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP08808137A 2008-07-07 2008-07-07 Process for purification of rabeprazole sodium Withdrawn EP2294064A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2008/000433 WO2010004571A2 (en) 2008-07-07 2008-07-07 Process for purification of rabeprazole sodium

Publications (2)

Publication Number Publication Date
EP2294064A2 EP2294064A2 (en) 2011-03-16
EP2294064A4 true EP2294064A4 (en) 2011-10-05

Family

ID=41507511

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08808137A Withdrawn EP2294064A4 (en) 2008-07-07 2008-07-07 Process for purification of rabeprazole sodium

Country Status (2)

Country Link
EP (1) EP2294064A4 (en)
WO (1) WO2010004571A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2391197B1 (en) * 2011-04-27 2013-07-16 Moehs Ibérica S.L. PROCEDURE FOR OBTAINING RABEPRAZOL SODIUM AMORFO.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006024890A1 (en) * 2004-08-30 2006-03-09 Apollo International Limited Improved process for rabeprazole sodium in amorphous form
WO2007023393A2 (en) * 2005-08-02 2007-03-01 Medichem, S.A. Novel processes for the production of amorphous rabeprazole sodium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1644352A1 (en) * 2003-07-15 2006-04-12 Allergan, Inc. Process for preparing isomerically pure prodrugs of proton pump inhibitors
BRPI0609622A2 (en) * 2005-03-30 2010-04-20 Lupin Ltd improved process for the production of rabeprazole sodium
WO2008146297A2 (en) * 2007-05-25 2008-12-04 Hetero Drugs Limited Improved process for amorphous rabeprazole sodium

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006024890A1 (en) * 2004-08-30 2006-03-09 Apollo International Limited Improved process for rabeprazole sodium in amorphous form
WO2007023393A2 (en) * 2005-08-02 2007-03-01 Medichem, S.A. Novel processes for the production of amorphous rabeprazole sodium

Also Published As

Publication number Publication date
WO2010004571A3 (en) 2010-12-29
EP2294064A2 (en) 2011-03-16
WO2010004571A2 (en) 2010-01-14

Similar Documents

Publication Publication Date Title
EP2291388A4 (en) Process for purification of antibodies
EP2334328A4 (en) Methods for purification of viruses
EP2271615A4 (en) Novel process for preparation of iopromide
EP2167429A4 (en) Process for purification of hydrocarbons
GB0808908D0 (en) Purification process
EP2407461A4 (en) Process for preparation of 1-alkyl-5-benzoyl-1h-tetrazole derivatives
EP2501651A4 (en) Process for purification of monosilane
IL219348A (en) Method for purification of colistin
EP2133356A4 (en) Process for production of phosphorus-containing -keto acid
EP2292579A4 (en) Process for production of halogenated -fluoroethers
ZA201101645B (en) Process for prodcution of vaccines
EP2165973A4 (en) Method for production of iodine heptafluoride
EP2088136A4 (en) Process for production of hydroxyadamantaneamine
EP2266943A4 (en) Method for producing of 2-alkyl-2-cycloalken-1-one
SI2303866T1 (en) Crystalline forms of rabeprazole sodium
PL2257537T3 (en) Process for purifying epichlorohydrins
GB0818228D0 (en) Purification process
EP2057151A4 (en) Process for purification of aprepitant
EP2346854A4 (en) Optical purification of esomeprazole
EP2221294A4 (en) Process for production of n-carbamoyl-tert-leucine
GB2459738B (en) Method of purification
EP2251329A4 (en) Process for production of 3-amino-2-chloro-6- trifluoromethylpyridine
EP2511234A4 (en) Process for production of ddr-type zeolite
EP2514783A4 (en) Process for production of organopolysiloxane compound
EP2281780A4 (en) Process for production of silicon

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100513

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20110901

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 401/12 20060101AFI20110826BHEP

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140201